Despite our focus on the PD-1/PD-L1 axis in this work, we recognize that other immunoregulatory pathways, such as TGF-β and CTLA-4, play significant roles in modulating tumor-immune dynamics. The gene discussed is TGFB1; the disease is neoplasm.